Characterization of VIM, VEB and CTX-M Beta-lactamase Gene in Escherichia coli and Pseudomonas aeruginosa Isolated from Urine Samples of Patients Visiting a Tertiary Hospital in Abakaliki
-
Published:2023-12-15
Issue:4
Volume:9
Page:7-11
-
ISSN:2394-8973
-
Container-title:International Journal of Medical Sciences and Pharma Research
-
language:
-
Short-container-title:Int J Med Sci Pharm Res
Author:
Ilang Donatus ChukwumaORCID, Peter Ikemesit UdemeORCID, Iroha Ifeanyichukwu RomanusORCID
Abstract
The spread and convergence of multiple beta-lactamase genes across distinct resistant bacterial populations from various hosts and settings demonstrates increased risk of morbidity and mortality in humans. This study was undertaken to characterize blaVIM, blaVEB and blaCTX-M beta-lactamase gene in Escherichia coli and P. aeruginosa isolates from patients visiting a tertiary hospital in Abakaliki. A total of three hundred (300) urine samples were collected from patients and were subjected to bacteriological examination using culture, Gram staining and biochemical technique, for routine microbiological identification and further confirmed using the VITEK-2 Automated System (Biomerieux, France). Antimicrobial susceptibility studies were determined using the Kirby–Bauer disk diffusion method. All isolate were further screen for various beta-lactamase resistant gene by PCR using specific primer. Of the 300 urine samples collected, prevalence rate of 187 (62.3%) and 91 (30.3 %) E. coli and P. aeruginosa were recorded. The isolates exhibited 50.0-100% percentage of resistance to Amoxycillin-Clavulanic acid, Azetronam, Cefoxitin, Ceftriaxone and Piperacillin/tazobactam. The proportion of beta-lactamase gene in E. coli were as follows (VEB 143/76.5 %; CTX-M 175/93.5 %; VIM 77/41.2 %) while beta-lactamase gene in P. aeruginosa were as follows (VEB 91/100 %; CTX-M 63/69.2%; VIM 48/52.7 %). The presence of these gene in our study indicates the possibility of therapeutic failure, serious consequences for infection control and increased risk of morbidity and mortality in patients. Hence, continuous effort in hospital surveillance, infection control, and clinical audits must be conducted to fight against the rapid development and spread of antibiotic-resistant bacteria pathogens.
Keywords: Beta-lactamase, Escherichia coli, Pseudomonas aeruginosa, VIM, VEB, CTX-M
Publisher
Society of Pharmaceutical Tecnocrats
Reference31 articles.
1. Yusof, N.Y., Norazzman, N.I.I., Hakim, S.N. W. A., Azlan, M.M., Anthony, A.A., Mustafa, F.H., Ahmed, N., Rabaan, A.A., Almuthree, S.A., Alawfi, A. Prevalence of Mutated Colistin-Resistant Klebsiella pneumoniae: A Systematic Review and Meta Analysis. Tropical Medicine and Infectious Disease, 7:414-419. https://doi.org/10.3390/tropicalmed7120414 PMid:36548669 PMCid:PMC9782491 2. Ogba, R. C., Nomeh, O. L, Edemekong, C. I., Nwuzo, A. C., Akpu, P. O., Peter, I. U and Iroha, I. R. Molecular Characterization of Carbapenemase Encoding Genes in Pseudomonas aeruginosa from Tertiary Healthcare in South Eastern Nigeria. Asian Journal of Biology, Genetic and Molecular Biology, 2022;12(4):161-168. https://doi.org/10.9734/ajbgmb/2022/v12i4281 3. Nomeh, L. O., Federica, O. I., Joseph, O. V., Moneth, E. C., Ogba, R. C., Nkechi, O. A., Peter, I. U., Akpu, P. O., Edemekong, C. I and Iroha, I. R. Detection of Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae Implicated in Urinary Tract Infection. Asian Journal of Research in Infectious Diseases, 2023;2 (1):15-23. https://doi.org/10.9734/ajrid/2023/v12i1234 4. Mustafai, M. M., Hafeez, M., Munawar, S., Basha, S., Rabaan, A. A., Halwani, M. A., Alawfi, A., Alshengeti, A., Najim, M. A and Alwarthan, S. Prevalence of Carbapenemase and Extended-Spectrum β-Lactamase Producing Enterobacteriaceae: A Cross-Sectional Study. Antibiotics, 2023;12:148-149 https://doi.org/10.3390/antibiotics12010148 PMid:36671350 PMCid:PMC9854900 5. Egwu, E., Ibiam, F. A, Moses, I. B., Iroha, C. S Orji, I., Okafor-Alu, F. N., Eze, C. O and Iroha, I. R. Antimicrobial Susceptibility and Molecular Characteristics of Beta-lactam- and Fluoroquinolone-resistant E. coli from Human Clinical Samples in Nigeria. Scientific African 2023;21:18-63 https://doi.org/10.1016/j.sciaf.2023.e01863
|
|